Tag: Breast cancer prevention

Blood hormone levels could be a key determinant in identifying women who will benefit from breast cancer prevention medication, according to a study by Queen Mary University of London. By measuring hormone levels through blood tests, post-menopausal women at high risk of breast cancer can be identified and receive tailored treatment with aromatase inhibitors. This personalized approach improves the effectiveness of preventative therapy and reduces unnecessary side effects. The findings contribute to ongoing efforts to address breast cancer and improve treatment outcomes.